Article Details

BioInvent to host Key Opinion Leader call on BI-1206 for relapsed or refractory Non-Hodgkin's ...

Retrieved on: 2021-01-20 10:41:15

Tags for this article:

Click the tags to see associated articles and topics

BioInvent to host Key Opinion Leader call on BI-1206 for relapsed or refractory Non-Hodgkin's .... View article details on hiswai:

Excerpt

Dr Jerkeman will also discuss his experience in treating these patients with BioInvent's anti-FcγRIIB antibody, BI-1206, a novel monoclonal antibody ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up